Biomarkers for identifying efficacy of tegaserod in patients with chronic constipation

Details for Australian Patent Application No. 2006204146 (hide)

Owner Novartis AG

Inventors McLean, LeeAnne

Agent Davies Collison Cave

Pub. Number AU-A-2006204146

PCT Pub. Number WO2006/074127

Priority 60/641,238 04.01.05 US

Filing date 3 January 2006

Wipo publication date 13 July 2006

International Classifications

A61K 31/404 (2006.01)

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/074127 Priority application(s): WO2006/074127

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204159-Novel pyridine compounds

2006204145-Heterogeneous, composite, carbonaceous catalyst system and methods that use catalytically active gold